Mannatech (NASDAQ:MTEX) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Thursday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

MTEX opened at $6.75 on Thursday. The stock has a market cap of $12.69 million, a price-to-earnings ratio of -7.58 and a beta of 1.17. Mannatech has a 1 year low of $6.75 and a 1 year high of $15.10. The company has a current ratio of 1.08, a quick ratio of 0.56 and a debt-to-equity ratio of 0.09. The stock has a fifty day moving average price of $7.76 and a 200 day moving average price of $8.35.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%. The company had revenue of $29.39 million for the quarter.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.